Brief: Eyenovia, Senju Pharmaceutical To Collaborate On Potential New Treatment For Chronic Dry Eye Disease
July 23 (Reuters) - Eyenovia Inc EYEN.O :
* EYENOVIA AND SENJU PHARMACEUTICAL CO., LTD. SIGN
COLLABORATION
AGREEMENT FOR POTENTIAL NEW TREATMENT FOR CHRONIC DRY EYE
DISEASE
* EYENOVIA INC - CO, SENJU PLANNING TO MEET WITH U.S. FDA TO
PRESENT CLINICAL DEVELOPMENT PROPOSAL
Source text for Eikon: ID:nGNXmmNvB
Further company coverage: EYEN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hyperion DeFi
See all newsHyperion DeFi Inc reports results for the quarter ended September 30 - Earnings Summary
Hyperion DeFi posts third straight record quarterly profit
Hyperion DeFi Inc expected to post earnings of $1.81 a share - Earnings Preview
Brief: Hyperion Defi Raises Guidance And Announces $20M Share Repurchase Program
Hyperion DeFi Inc reports results for the quarter ended June 30 - Earnings Summary